Trial NCT03565406

View at ClinicalTrials.gov 
Org. Study IDs: 17-00861

Last trial update was posted on 2020-05-21

MeSH Interventions

Ipilimumab Mocetinostat Nivolumab

MeSH Conditions

Melanoma

Other Conditions


Stopping Reasons

recruiting or enrolling participants has halted prematurely and will not resume; participants are no longer being examined or treated

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID